Conversion from regular cyclosporine to microemulsion cyclosporine following heart transplantation.
Heroux
A L
AL
Heart Failure, Heart Transplantation Program, Quebec City Heart Institute, Hôpital Laval, Canada.
LeBlanc
M H
MH
Beaudoin
D
D
Simard
S
S
Coulombe
D A
DA
Gleeton
O
O
Lemieux
M D
MD
Doyle
D P
DP
D001379:Azathioprine / Q000627:therapeutic use; D001707:Biopsy, Needle; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004655:Emulsions; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D013997:Time Factors
D004655:Emulsions; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine; D001379:Azathioprine; D011241:Prednisone